Salient to Investors: The Fed needs to be audited to determine if it has manipulated financial markets, which is not in its jurisdiction. Autonomy for the Fed ended when it started playing footsie with Wall Street. The bubble in stock prices was created by years of risky Fed policy. Even the
READ MORE... →Salient to Investors: Bloomberg and Pavilion Global Markets report 12 stock-sale announcements over the past 3 months for every purchase by insiders at S&P 500 companies, the highest ratio since January 2011. Pavilion said readings above 11 historically preceded average declines of 5.9 percent over the following 6 months. The ratio of sales
READ MORE... →Salient to Investors: Michael T. Snyder writes: The US economy is slowing down – freight volumes and expenditures are way down, consumer confidence is down sharply, major retail chains are closing hundreds of stores, the sequester threatens to bring austerity. gas prices are rising rapidly, corporate insiders are dumping massive
READ MORE... →Salient to Investors: The SEC is increasing its focus on insider trading by overseas buyers of US-traded securities. Overseas trading probes present significant obstacles to criminal charges. Foreign insider traders, while at some risk of losing their money, face very little chance of going to prison. The significant number of cross-border transactions
READ MORE... →Salient to Investors: Since 2008, at least 94 of the 400 people sued by regulators or charged with insider trading passed or received tips involving pharmaceutical, biotech or other health-care stocks. Read the full article at http://www.bloomberg.com/news/2012-11-27/harvard-doctor-turns-felon-after-lure-of-insider-trading.html
READ MORE... →Salient to Investors: Markets are awash in insider trading, and healthcare has been particularly hard-hit since it offers illegal traders more opportunities to profit than the finance and technology sectors. Health companies can live or die on the results of drug trials and the industry has undergone significant consolidation. What’s notable about
READ MORE... →